Article Access statistics

Viewed: 209

Emailed: 0

PDF Downloaded: 158

IP Indian Journal of Immunology and Respiratory Medicine


A study of polycythaemia and associated factors in COPD patients attending a tertiary care hospital


Full Text PDF Share on Facebook Share on Twitter


Original Article

Author Details : Veerabhadrappa K. Kuppast, H B Chandrashekar, Umesh Y Ramadurg*

Volume : 5, Issue : 2, Year : 2020

Article Page : 101-104


Suggest article by email

Abstract

Background: Prevalence of polycythaemia amongst patients with COPD and its long term effects are
unknown. There is limited information in the current literature describing the distribution of haemoglobin
(Hb) and its impact on outcomes in the COPD population. The purpose of the present study was to
determine the prevalence of polycythaemia in patients with COPD attending a pulmonary clinic, as well as
to explore the associations between Hb levels and clinical outcomes.
Materials and Methods: A case series descriptive study was conducted on 50 patients of COPD attending
pulmonary OPD of a tertiary care hospital.
Results: All subjects were male and were aged between 40-85 years. Mean age among of COPD patients
with anaemia was 62.00 10.37yrs and with polycythaemia was 62.86 9.03yrs. Amongst COPD patients
with polycythaemia mean BMI was 18.49 3.78. Severity of smoking pack years among the patient group
was maximum of 60 pack years and minimum of 20 pack years. Mean value of PCV among patients with
polycythaemia and without polycythaemia were 56.292.87 and 41.09 4.18 respectively.
Conclusions: Polycythaemia did not seem to be related with either increased COPD severity or with altered
outcomes.

Keywords: Polycythaemia, Anaemia, COPD tertiary care hospital


Doi : 10.18231/j.ijirm.2020.038

How to cite : Kuppast V K, Chandrashekar H B, Ramadurg U Y, A study of polycythaemia and associated factors in COPD patients attending a tertiary care hospital. IP Indian J Immunol Respir Med 2020;5(2):101-104

Copyright © 2020 by author(s) and IP Indian J Immunol Respir Med. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)